未登录

D

Daniel T. Monaghan

University of Nebraska

H指数:47

被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Contribution of astrocytic calcium signaling to auditory hypersensitivity in a mouse model of fragile X syndrome

星形胶质细胞钙信号对脆性X综合征小鼠模型听觉超敏反应的贡献

Neurobiology of Disease

IF5.6

2026-03-170

OAAI

Structural basis of subtype-selective competitive antagonism for GluN2C/2D-containing NMDA receptors

NATURE COMMUNICATIONS

IF15.7

2020-01-2219

OAAI

Investigation of the structural requirements for N-methyl-D-aspartate receptor positive and negative allosteric modulators based on 2-naphthoic acid

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2019-02-0112

OAAI

The NMDA receptor intracellular C-terminal domains reciprocally interact with allosteric modulators

NMDA受体细胞内C末端结构域与变构调节剂相互作用

BIOCHEMICAL PHARMACOLOGY

IF5.6

2019-01-0119

OAAI

In the Telencephalon, GluN2C NMDA Receptor Subunit mRNA is Predominately Expressed in Glial Cells and GluN2D mRNA in Interneurons

NEUROCHEMICAL RESEARCH

IF3.8

2018-04-1238

OAAI

Positive and Negative Allosteric Modulators of N-Methyl-D-aspartate (NMDA) Receptors: Structure-Activity Relationships and Mechanisms of Action

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2018-02-1543

OAAI

A single-channel mechanism for pharmacological potentiation of GluN1/GluN2A NMDA receptors

SCIENTIFIC REPORTS

IF3.9

2017-07-318

OAAI

The NMDA receptor GluN2C subunit controls cortical excitatory-inhibitory balance, neuronal oscillations and cognitive function

SCIENTIFIC REPORTS

IF3.9

2016-12-0655

OAAI

Bidirectional Effect of Pregnenolone Sulfate on GluN1/GluN2A N-Methyl-D-Aspartate Receptor Gating Depending on Extracellular Calcium and Intracellular Milieu

MOLECULAR PHARMACOLOGY

IF3

2015-10-0114

OAAI

Coumarin-3-carboxylic acid derivatives as potentiators and inhibitors of recombinant and native N-methyl-D-aspartate receptors

NEUROCHEMISTRY INTERNATIONAL

IF4

2012-09-0141

OA

Pharmacological modulation of NMDA receptor activity and the advent of negative and positive allosteric modulators

NEUROCHEMISTRY INTERNATIONAL

IF4

2012-09-0180

OA

Piperazine-2,3-dicarboxylic Acid Derivatives as Dual Antagonists of NMDA and GluK1-Containing Kainate Receptors

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2011-12-1420

OAAI

Selective inhibition of GluN2D-containing N-methyl-D-aspartate receptors prevents tissue plasminogen activator-promoted neurotoxicity both in vitro and in vivo

MOLECULAR NEURODEGENERATION

IF17.5

2011-10-0533

OAAI

A Novel Family of Negative and Positive Allosteric Modulators of NMDA Receptors

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

IF3.8

2010-12-0199

OAAI

N-Methyl-D-aspartate (NMDA) Receptor NR2 Subunit Selectivity of a Series of Novel Piperazine-2,3-dicarboxylate Derivatives: Preferential Blockade of Extrasynaptic NMDA Receptors in the Rat Hippocampal CA3-CA1 Synapse

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

IF3.8

2009-11-0159

OAAI

Structure-activity analysis of a novel NR2C/NR2D-preferring NMDA receptor antagonist: 1-(phenanthrene-2-carbonyl)piperazine-2,3-dicarboxylic acid

BRITISH JOURNAL OF PHARMACOLOGY

IF7.7

2009-01-30151

OAAI

Calcium-permeable AMPA receptors containing Q/R-unedited GluR2 direct human neural progenitor cell differentiation to neurons

IF4.2

2008-04-1089

OAAI

Interaction with σ1 protein, but not N-methyl-D-aspartate receptor, is involved in the pharmacological activity of donepezil

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

IF3.8

2006-05-0176

PREAI

Identification of subunit- and antagonist-specific amino acid residues in the N-methyl-D-aspartate receptor glutamate-binding pocket

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

IF3.8

2005-06-0145

PREAI

Synthesis and pharmacology of N1-substituted piperazine-2,3-dicarboxylic acid derivatives acting as NMDA receptor antagonists

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2005-02-1860

PREAI